Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 10, Issue 2

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Drug Safety, Volume 10, Issue 2 (2011)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 10, Issue 2 (2011)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Volume 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

Capecitabine and hand–foot syndrome

Muhammad Wasif Saif MD MBBS

Pages: 159-169

Published online: 22 Dec 2010

AbstractforCapecitabine and hand–foot syndrome | Full Text | References | PDF (347.4 KB)

1083 Views
38 CrossRef citations
0Altmetric

Original Research

Article

Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases

Oliver A Cornely, Peter G Pappas, Jo-Anne H Young, Philip Maddison & Andrew J Ullmann

Pages: 171-183

Published online: 10 Feb 2011

AbstractforAccumulated safety data of micafungin in therapy and prophylaxis in fungal diseases | Full Text | References | PDF (414.9 KB) | Supplemental

542 Views
26 CrossRef citations
0Altmetric

Article

Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients

Jürgen Scholze, Angie Schaefer & Reinhold Kreutz

Pages: 185-196

Published online: 23 Jan 2011

AbstractforSafety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients | Full Text | References | PDF (366.3 KB)

209 Views
7 CrossRef citations
0Altmetric

Article

A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis

James M Littlewood, Gary J Connett, Suntje Sander-Struckmeier, Friederike Henniges, the Creon 40,000 Study Group & the Creon 40,000 Study Group

Pages: 197-203

Published online: 23 Feb 2011

AbstractforA 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis | Full Text | References | PDF (335.3 KB)

323 Views
10 CrossRef citations
0Altmetric

Reviews

Article

The role and efficacy of denosumab in the treatment of osteoporosis: an update

Ioannis Charopoulos MD PhD, Steve Orme MBBS FRCP & Peter V Giannoudis MD FRCS

Pages: 205-217

Published online: 06 Jan 2011

AbstractforThe role and efficacy of denosumab in the treatment of osteoporosis: an update | Full Text | References | PDF (229.1 KB)

385 Views
17 CrossRef citations
0Altmetric

Article

Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis

Amr A Saad PhD, Kimme L Hyrich MD PhD FRCPC & Darren M Ashcroft PhD

Pages: 219-226

Published online: 06 Jan 2011

AbstractforDrug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis | Full Text | References | PDF (193.5 KB)

292 Views
4 CrossRef citations
0Altmetric

Article

Oral hypoglycemic agents for gestational diabetes mellitus?

Ana Cristina Maymone DVM, Jean-Patrice Baillargeon MD MSc, Julie Ménard PhD & Jean-Luc Ardilouze MD PhD

Pages: 227-238

Published online: 06 Jan 2011

AbstractforOral hypoglycemic agents for gestational diabetes mellitus? | Full Text | References | PDF (327.1 KB)

718 Views
28 CrossRef citations
0Altmetric

Article

Efalizumab

Marina Talamonti, Giulia Spallone, Alessandro Di Stefani, Antonio Costanzo & Sergio Chimenti

Pages: 239-251

Published online: 10 Jan 2011

AbstractforEfalizumab | Full Text | References | PDF (303.8 KB)

411 Views
39 CrossRef citations
0Altmetric

Article

Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity

Victoria Linares PhD, Virginia Alonso PhD & José L Domingo PhD

Pages: 253-263

Published online: 10 Jan 2011

AbstractforOxidative stress as a mechanism underlying sulfasalazine-induced toxicity | Full Text | References | PDF (307.1 KB)

625 Views
72 CrossRef citations
0Altmetric

Article

Influences of bone and mineral metabolism in epilepsy

Sherifa A Hamed MBBch MSc MD

Pages: 265-280

Published online: 15 Feb 2011

AbstractforInfluences of bone and mineral metabolism in epilepsy | Full Text | References | PDF (326.4 KB)

289 Views
17 CrossRef citations
0Altmetric

Article

Safety of micafungin in infants: insights into optimal dosing

Simon Ascher BS, Phillip Brian Smith MD MPH MHS & Daniel K Benjamin Jr MD PhD MPH

Pages: 281-286

Published online: 13 Jan 2011

AbstractforSafety of micafungin in infants: insights into optimal dosing | Full Text | References | PDF (179.8 KB)

239 Views
24 CrossRef citations
0Altmetric

Drug Safety Evaluations

Article

Mirabegron: a safety review

Pradeep Tyagi, Vikas Tyagi & Michael Chancellor

Pages: 287-294

Published online: 09 Dec 2010

AbstractforMirabegron: a safety review | Full Text | References | PDF (238.6 KB)

1131 Views
35 CrossRef citations
0Altmetric

Article

A drug safety evaluation of valsartan

Roberto Fogari & Annalisa Zoppi

Pages: 295-303

Published online: 11 Dec 2010

AbstractforA drug safety evaluation of valsartan | Full Text | References | PDF (288.9 KB)

689 Views
11 CrossRef citations
0Altmetric

Article

Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes

Nicholas Avitabile MD, Ajaz Banka & Vivian A Fonseca

Pages: 305-310

Published online: 19 Jan 2011

AbstractforSafety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes | Full Text | References | PDF (217.4 KB)

131 Views
11 CrossRef citations
0Altmetric

Article

Pemetrexed in advanced non-small cell lung cancer

Cesare Gridelli MD, Paolo Maione MD, Antonio Rossi, Maria Anna Bareschino MD, Clorinda Schettino MD, Paola Claudia Sacco MD & Rosario Zeppa

Pages: 311-317

Published online: 25 Jan 2011

AbstractforPemetrexed in advanced non-small cell lung cancer | Full Text | References | PDF (188.1 KB)

359 Views
11 CrossRef citations
0Altmetric

Meeting Highlights

Article

10^th annual meeting of the Safety Pharmacology Society: an overview

Icilio Cavero PhD

Pages: 319-333

Published online: 14 Feb 2011

Abstractfor10^th annual meeting of the Safety Pharmacology Society: an overview | Full Text | References | PDF (260.9 KB)

160 Views
8 CrossRef citations
0Altmetric

Appendix

Correction

Erratum

Page: 335

Published online: 23 Feb 2011

CitationforErratum | Full Text | PDF (24.5 KB)

345 Views
0 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile

André J. Scheen

Review Article | Published online: 13 May 2024

Differences in Ocular Adverse Events Associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study

Zhiwen Fu et al.

Article | Published online: 13 May 2024

Comparison of safety of acetaminophen and ibuprofen in minors: based on the FAERS database

Jing Wang et al.

Article | Published online: 12 May 2024

A real-world disproportionality analysis of the FDA adverse event reporting system events for ibuprofen

Yikuan Du et al.

Article | Published online: 9 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.10, Iss.2, 2011)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?